Palisade Bio (PALI) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.14% |
| Dec 31, 2025 | -2,432.98% |
| Sep 30, 2025 | 3.51% |
| Jun 30, 2025 | 25.08% |
| Mar 31, 2025 | 25.94% |
| Dec 31, 2024 | -21.43% |
| Sep 30, 2024 | 29.18% |
| Jun 30, 2024 | -0.68% |
| Mar 31, 2024 | 9.30% |
| Dec 31, 2023 | 18.81% |
| Sep 30, 2023 | 6.65% |
| Jun 30, 2023 | -23.36% |
| Mar 31, 2023 | -7.38% |
| Dec 31, 2022 | 11.46% |
| Sep 30, 2022 | -180.82% |
| Jun 30, 2022 | 25.05% |
| Mar 31, 2022 | 36.69% |
| Dec 31, 2021 | 25.59% |
| Sep 30, 2021 | -11.47% |
| Jun 30, 2021 | -1,957.40% |
| Mar 31, 2021 | 13.74% |
| Dec 31, 2020 | 5.06% |
| Sep 30, 2020 | 50.56% |
| Jun 30, 2020 | 84.86% |
| Mar 31, 2020 | -96.09% |
| Dec 31, 2019 | 29.93% |
| Sep 30, 2019 | -219.97% |
| Jun 30, 2019 | 43.04% |
| Mar 31, 2019 | 30.79% |
| Dec 31, 2018 | -0.87% |
| Sep 30, 2018 | 19.12% |
| Jun 30, 2018 | 27.06% |
| Mar 31, 2018 | 16.71% |
| Dec 31, 2017 | 16.99% |
| Sep 30, 2017 | -22.91% |
| Jun 30, 2017 | 31.40% |
| Mar 31, 2017 | 17.40% |
| Dec 31, 2016 | -255.79% |
| Sep 30, 2016 | 49.00% |
| Jun 30, 2016 | -46.03% |
| Mar 31, 2016 | 37.71% |
| Dec 31, 2015 | 32.59% |
| Sep 30, 2015 | 23.37% |
| Jun 30, 2015 | 17.27% |
| Mar 31, 2015 | -3.99% |
| Dec 31, 2014 | -2.13% |
| Sep 30, 2014 | 10.85% |
| Jun 30, 2014 | 9.33% |
| Mar 31, 2014 | -97.93% |
| Dec 31, 2013 | -2.71% |
| Sep 30, 2013 | -46.89% |
| Jun 30, 2013 | 11.80% |
| Mar 31, 2013 | -70.06% |
| Dec 31, 2012 | 24.61% |
| Sep 30, 2012 | -288.79% |
| Jun 30, 2012 | 50.63% |
| Mar 31, 2012 | -118.71% |
| Dec 31, 2011 | 43.94% |
| Sep 30, 2011 | 31.69% |
| Jun 30, 2011 | 28.14% |
| Mar 31, 2011 | 7.72% |
| Dec 31, 2010 | 20.08% |
| Sep 30, 2010 | 17.37% |